Clinical Trial Update: Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating disulfiram in combination with chemotherapy for patients with refractory solid tumors or metastatic pancreatic cancer has been terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Disulfiram (Disulfiram)

Snippet

Sponsor: Mayo Clinic | Conditions: Metastatic Pancreatic Adenocarcinoma, Refractory Malignant Solid Neoplasm | Phase 1 | Status: TERMINATED